Search Results

REVIAN Inc. (formerly PhotonMD Inc.) – a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light – is excited to announce that final data from a randomized, double-blind study of the REVIAN RED hair growth system was presented at the 2020 Winter Clinical Dermatology Conference - Hawaii®.

REVIAN Inc. (formerly PhotonMD Inc.), a medical technology company dedicated to stimulating the body’s natural processes to rejuvenate hair and skin with light, is pleased to announce that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,265,258 - the seminal patent on the use of proprietary color combinations of light to regenerate living tissue in the body.

Brian Johnson accepts role as new leader of REVIAN business unit focused on regenerating hair and skin with light

New Trial Data Shows Favorable Results Compared to Data Published for Directly Competing Hair Loss Treatments

Light therapy or phototherapy is a treatment type wherein a patient is exposed to an artificial light source. It affects brain chemicals linked to mood and sleep, and also helps to reset the circadian rhythms, which control the sleep-wake cycle.

Nitric oxide release technology will have broad applications for unmet needs in diabetic health management

Follows $25 Million in Corporate Commitment Last December

Company benefits from research with large pharma partner Nitric oxide powder technology will have broad applications for unmet needs in gastrointestinal health